Many patients experience improvements in: Type 2 diabetes Prediabetes Blood pressure Cholesterol Fatty liver disease Sleep apnea Joint pain Mobility Energy levels Quality of life Some GLP-1 medications have also demonstrated cardiovascular and kidney benefits in people with type 2 diabetes and established cardiovascular disease
Technological processes such as popping increase the fraction of inaccessible or retrograded starch, increasing the resistant starch content and expanding the functional potential of the grain (Gupta et al., 2023
If you're ready to see which of our science-forward formulations might be the best fit for your unique needs, we invite you to take our Health Quiz today
Medicare has historically not covered weight-loss-only indications, though the 2026 GLP-1 Bridge program provides temporary access to Foundayo at $50/month through December
However, since these measures require no data submission, using performance period benchmarks allows for the calculation of more current and representative measure scores that better track clinician performance and progress over time
